Bioter S.A. (BIOT) - Cash Flow Conversion Efficiency

Latest as of December 2022: 0.023x

Based on the latest financial reports, Bioter S.A. (BIOT) has a cash flow conversion efficiency ratio of 0.023x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.46 Million ≈ $-2.88 Million USD) by net assets (€-106.17 Million ≈ $-124.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bioter S.A. defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Bioter S.A. - Cash Flow Conversion Efficiency Trend (2014–2022)

This chart illustrates how Bioter S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bioter S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioter S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Cann Group Ltd
AU:CAN
0.000x
Pool Safe Inc
V:POOL
-3.557x
Netcapital Inc
NASDAQ:NCPL
-0.040x
Conduit Pharmaceuticals Inc.
NASDAQ:CDT
-0.015x
ARC Funds Ltd
AU:ARC
-0.304x
H&T Group plc
LSE:HAT
0.033x
Volcanic Gold Mines Inc
V:VG
-0.192x
Sherpa II Holdings Corp
V:SHRP
-0.046x

Annual Cash Flow Conversion Efficiency for Bioter S.A. (2014–2022)

The table below shows the annual cash flow conversion efficiency of Bioter S.A. from 2014 to 2022. For the full company profile with market capitalisation and key ratios, see BIOT company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 €-106.17 Million
≈ $-124.12 Million
€-9.46 Million
≈ $-11.06 Million
0.089x +34.82%
2021-12-31 €-96.49 Million
≈ $-112.81 Million
€-6.38 Million
≈ $-7.45 Million
0.066x -36.34%
2020-12-31 €-87.69 Million
≈ $-102.52 Million
€-9.10 Million
≈ $-10.64 Million
0.104x +51.53%
2019-12-31 €-93.64 Million
≈ $-109.48 Million
€-6.41 Million
≈ $-7.50 Million
0.068x -17.40%
2018-12-31 €-85.02 Million
≈ $-99.39 Million
€-7.05 Million
≈ $-8.24 Million
0.083x -57.38%
2017-12-31 €-71.39 Million
≈ $-83.47 Million
€-13.89 Million
≈ $-16.24 Million
0.195x +47.08%
2016-12-31 €-54.16 Million
≈ $-63.32 Million
€-7.16 Million
≈ $-8.38 Million
0.132x -46.53%
2015-12-31 €-35.44 Million
≈ $-41.43 Million
€-8.77 Million
≈ $-10.25 Million
0.247x -34.62%
2014-12-31 €-25.33 Million
≈ $-29.61 Million
€-9.58 Million
≈ $-11.20 Million
0.378x --

About Bioter S.A.

AT:BIOT Greece Engineering & Construction
Market Cap
$4.03 Million
€3.45 Million EUR
Market Cap Rank
#29187 Global
#111 in Greece
Share Price
€0.21
Change (1 day)
+0.00%
52-Week Range
€0.21 - €0.21
All Time High
€0.58
About

Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more